Back to Pulse

What Changes in the Human Hippocampus with Age?

Conceptual cross-section of human hippocampal tissue with support cells, microglia-like cells and folded chromatin inside a cell nucleus.

A study of 40 postmortem brains maps a midlife shift in immune cells and a wider loss of cellular and genome organisation—but it does not show how to prevent cognitive decline.

The hippocampus helps form memories and navigate space. It is also one of the brain regions that changes with age. A new cell-by-cell map offers a closer look at what those changes involve.

The study does not identify a treatment or prove why memory declines. Its value is more basic: it shows several biological systems changing together in the same human tissue.

What the researchers studied

The team analysed postmortem hippocampal tissue from 40 neurologically healthy adults aged 20 to 95. The sample was divided into four age groups, with ten donors in each and an equal number of males and females.

Using single-nucleus methods, the researchers measured four layers of biology: gene activity, how accessible different DNA regions were, DNA methylation and the three-dimensional contacts that help organize DNA inside the nucleus. This allowed them to compare cell types and regulatory changes across the adult age range. [1]

Study design and interpretation boundary. Source: [1].

Three changes stood out

First, the proportion of several support-cell populations declined with age. These included astrocytes, which help regulate synapses and support the environment around neurons; oligodendrocyte precursor cells; and endothelial cells associated with blood vessels. Tissue imaging in a smaller set of samples supported the age-related loss of astrocytes. [1]

Second, the study found a change in microglia, the brain's resident immune cells. Between roughly ages 50 and 75, cells with the signature of embryonic yolk-sac-derived microglia became less common, while cells resembling microglia derived from circulating monocytes became more prominent. The later population carried molecular features consistent with a more immune-primed state. [1]

Third, the three-dimensional organization of the genome became less orderly across several cell types. DNA is not stored as a loose thread inside the nucleus; its folding helps determine which genes can be used. The researchers linked changes in that organization to altered chromatin accessibility, methylation and gene activity. [1]

What the study means

The findings support a view of brain ageing as coordinated remodeling rather than a single switch. Immune cells, support cells and genome regulation changed together in the hippocampus.

That makes the dataset useful for generating better questions. Which changes are causes, which are responses, and which are protective adaptations? Could the immune-cell transition help explain vulnerability to neurodegeneration, or is it simply a marker of ageing tissue? The study cannot answer those questions yet. The NIH summary says future work must test what drives the loss of resident microglia and whether the transition contributes directly to Alzheimer's disease or other disorders. [2]

The limits matter

This was a cross-sectional postmortem study. It compared different people at different ages; it did not follow the same brains over time. Forty donors can reveal coherent molecular patterns, but it is not enough to define a universal timetable for brain ageing.

The study also did not measure memory change, dementia risk or the effect of an intervention. Its findings come from the hippocampus and should not be treated as a map of the whole brain. Postmortem conditions and differences in how cell types are recovered can also affect single-nucleus data, although tissue imaging provided an independent check for part of the astrocyte result.

Bottom line

The paper provides a detailed human map of how hippocampal cells and their genome regulation differ across adulthood. It identifies a notable immune-cell transition in midlife and broader changes in support cells and DNA organization. Those observations are important starting points—not evidence that a particular test, supplement or treatment can slow brain ageing.

Sources